Interferon-γ regulates oxidative stress during experimental autoimmune encephalomyelitis

Experimental Neurology

Volumn 177, Issue 1, 2002, Pages 21-31

  Espejo, Carmen ^a   Penkowa, Milena ^b   Sáez Torres, Irene ^a   Hidalgo, Juan ^c   García, Agustina ^c   Montalban, Xavier ^a   Martínez Cáceres, Eva M ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Experimental autoimmune encephalomy elitis; IFN ; Multiple sclerosis; Neurodegeneration; Oxidative stress

Indexed keywords

3 NITROTYROSINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; MALONALDEHYDE; METALLOTHIONEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE SYNTHASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOASSAY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WILD TYPE;

EID: 0036432916     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.7982     Document Type: Article

References (55)

1. Andrews, G. K. 2000. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 59: 95-104.
2. Aschner, M. 1997. Astrocyte metallothioneins (MTs) and their neuroprotective role. Ann. N. Y. Acad. Sci. 825: 334-347.
3. Aschner, M., M. G. Cherian, C. D. Klaassen, R. D. Palmiter, J. C. Erickson, and A. I. Bush. 1997. Metallothioneins in brain - The role in the physiology and pathology. Toxicol. Appl. Pharmacol. 142: 229-242.
4. Benveniste, E. N. 1997. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75: 165-173.
5. Billiau, A., H. Heremans, F. Vandekerckhove, R. Dijkmans, H. E. Sobis, H. Meulepas, and H. Carton. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140: 1506-1510.
6. Brocke, S., K. Gijbels, and L. Steinman. 1994. In Autoimmune Disease Models: A Guidebook (I. R. Cohen and A. Miller, Eds.), pp. 1-14. Academic Press, San Diego.
7. Chu, C. Q., S. Wittmer, and D. K. Dalton. 2000. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192: 123-128.
8. Cross, A. H., R. M. Keeling, S. Goorha, M. San, C. Rodi, P. S. Wyatts, P. T. Manning, and T. P. Misko. 1996. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine EAE. J. Neuroimmunol. 71: 145-153.
9. De Groot, C. J., S. R. Ruuls, J. W. Theeuwes, C. D. Dijkstra, and P. Van der Valk. 1997. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56: 10-20.
10. Duong, T. T., F. D. Finkelman, B. Singh, and G. H. Strejan. 1994. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53: 101-107.
11. Duong, T. T., J. St. Louis, J. J. Gilbert, F. D. Finkelman, and G. H. Strejan. 1992. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of an actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36: 105-115.
12. Eng, L. F., R. S. Ghirnikar, and Y. L. Lee. 1996. Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem. Res. 21: 511-525.
13. Espejo, C., J. Carrasco, J. Hidalgo, M. Penkowa, A. García, I. Sáez-Torres, and E. M. Martinez-Cáceres. 2001. Differential expression of metallothionein in the CNS of mice with experimental autoimmune encephalomyelitis. Neuroscience 105: 1055-1065.
14. Espejo, C., M. Penkowa, I. Sáez-Torres, J. Xaus, A. Celada, X. Montalban, and E. M. Martinez-Cáceres. 2001. Treatment with anti-interferon-γ monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-γ receptor knockout mice. Exp. Neurol. 172: 460-468.
15. Ferber, I. A., S. Brocke, C. Taylor-Edward, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted interferon-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156: 5-7.
16. Furlan, R., E. Brambilla, F. Ruffini, P. L. Poliani, A. Bergami, P. C. Marconi, D. M. Franciotta, G. Penna, G. Comi, L. Adorini, and G. Martino. 2001. Intrathecal delivery of IFN-γ protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J. Immunol. 167: 1821-1829.
17. Gasull, T., D. V. Rebollo, B. Romero, and J. Hidalgo. 1993. Development of a competitive double antibody radioimmunoassay for rat metallothionein. J. Immunoassay 14: 209-225.
18. Giralt, M., M. Penkowa, J. Hernández, A. Molinero, J. Carrasco, N. Lago, J. Camats, I. L. Campbell, and J. Hidalgo. 2002. Metallothionein-I3II deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. Neurobiol. Dis. 9: 319-338.
19. Hartung, H. P. 1997. Pathogenesis of multiple sclerosis. In Frontiers in Multiple Sclerosis: Clinical Research and Therapy (O. Abramsky and H. Ovadia, Eds.), pp. 45-59. Dunitz, London.
20. Hartung, H. P., S. Jung, G. Stoll, J. Zielasek, B. Schimidt, J. J. Archelos, and K. V. Toyka. 1992. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40: 197-210.
21. Heber-Katz, E. 1993. The ups and downs of EAE. Int. Rev. Immunol. 9: 277-285.
22. Heremans, H., C. Dillen, M. Groenen, E. Martens, and A. Billiau. 1996. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: Enhancement by monoclonal antibodies against interferon-γ. Eur. J. Immunol. 26: 2393-2398.
23. Hidalgo, J., B. Castellano, and I. L. Campbell. 1997. Regulation of brain metallothioneins. Curr. Top. Neurochem. 1: 1-25.
24. Hidalgo, J., M. Aschner, P. Zatta, and M. Vasák. 2001. Roles of the metallothionein family of proteins in the central nervous system. Brain Res. Bull. 55: 133-145.
25. Hooper, D. C., S. T. Ohnishi, R. Kean, Y. Numagami, B. Dietzschold, and H. Koprowski. 1995. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92: 5312-5316.
26. Horwitz, M., C. Evans, D. McGavern, M. Rodríguez, and M. Oldstone. 1997. Primary demyelination in transgenic mice expressing interferon-gamma. Nat. Med. 3: 1037-1041.
27. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259: 1742-1745.
28. Krakowski, M., and T. Owens. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26: 1641-1646.
29. Lin, R. F., T.-S. Lin, R. G. Tilton, and A. H. Cross. 1993. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: An electron paramagnetic resonance study. J. Exp. Med. 178: 643-648.
30. Martin, R., and H. F. McFarland. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32: 121-182.
31. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2(b)mice: Fine specificity and T cell receptor Vb expression of encephalitogenic T cell. Eur. J. Immunol. 25: 1951-1959.
32. Olsson, T. 1992. Cytokines in neuroinflammatory disease: Role of myelin autoreactive T cell production of interferon-gamma. J. Neuroimmunol. 40: 211-218.
33. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144: 245-268.
34. Panitch, H. S. 1992. Interferons in multiple sclerosis. Drugs 44: 946-962.
35. Panitch, H. S., R. I. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with gamma-interferon. Lancet i: 893-895.
36. Panitch, H. S., R. I. Hirsch, J. Schindler, and K. P. Johnson. 1987. Treatment of multiple sclerosis with interferon-gamma: Exacerbation associated with activation of immune system. Neurology 37: 1.
37. Penkowa, M., C. Espejo, E. M. Martinez-Cáceres, C. B. Poulsen, X. Montalban, and J. Hidalgo. 2001. Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 119: 248-260.
38. Penkowa, M., J. Carrasco, M. Giralt, A. Molinero, J. Hernández, I. L. Campbell, and J. Hidalgo. 2000. Prolonged inflammatory response to traumatic brain injury in metalothionein-I+II deficient mice. J. Cereb. Blood Flow Metab. 20: 1174-1190.
39. Penkowa, M., J. Carrasco, M. Giralt, T. Moos, and J. Hidalgo. 1999. CNS wound healing is severely depressed in metallothionein-I and II-deficient mice. J. Neurosci. 19: 2535-2545.
40. Penkowa, M., M. Giralt, J. Carrasco, H. Hadberg, and J. Hidalgo. 2000. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6 deficient mice. Glia 32: 271-285.
41. Penkowa, M., M. Giralt, T. Moos, P. S. Thomsen, J. Hérnandez, and J. Hidalgo. 1999. Impaired inflammatory response to glial cell death in genetically metallothionein-I+II deficient mice. Exp. Neurol. 156: 149-164.
42. Penkowa, M., and J. Hidalgo. 2000. Metallothionein I+II (MT-I+II) expression and their role in experimental autoimmune encephalomyelitis (EAE). Glia 32: 247-263.
43. Penkowa, M., J. Hidalgo, and T. Moos. 1997. Increased astro-cytic expression of metallothioneins I+II in brain stem of adult rats treated with 6-aminonicotinamide. Brain Res. 774: 256-259.
44. Penkowa, M., T. Moos, J. Carrasco, H. Hadberg, A. Molinero, H. Bluethmann, and J. Hidalgo. 1999. Strongly compromised inflammatory response to brain injury in interleukin-6 deficient mice. Glia 25: 343-357.
45. Raine, C. S. 1992. Demyelinating diseases. In Textbook of Neuropathology (R. L. Davis and D. M. Robertson, Eds.), pp. 535-552. Williams & Wilkins, Baltimore.
46. Sato, M., and I. Bremner. 1993. Oxygen free radicals and metallothionein. Free Radical Biol. Med. 14: 325-337.
47. Sethna, M., and L. Lampson. 1991. Immune modulation within the brain: Recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J. Neuroimmunol. 34: 121-132.
48. Simmons, R. D., and D. O. Willenborg. 1990. Direct injection into spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100: 37-42.
49. Tanuma, N., T. Shin, K. Kojure, and Y. Matsumoto. 1999. Differential role of TNF-α and IFN-γ in the brain of rats with chronic relapsing autoimmune encephalomyelitis. J. Neuroimmunol. 96: 73-79.
50. Vladimirova, O., J. O'Connor, A. Cahill, H. Alder, C. Butonoi, and B. Kalman. 1998. Oxidative damage to DNA in plaques of MS brains. Mult. Scler. 4: 413-418.
51. Wekerle, H. 1993. T-cell autoimmunity in the central nervous system. Intervirology 35: 95-100.
52. Wiemann, B., G. Y. Van, D. M. Danilenko, Q. Yan, C. Matheson, L. Munyakazi, S. Ogenstad, and C. O. Starnes. 1998. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist. Exp. Neurol. 149: 455-463.
53. Willenborg, D. O., S. A. Fordham, C. C. A. Bernard, W. B. Cowden, and I. A. Ramshaw. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157: 3223-3227.
54. Willenborg, D. O., S. A. Fordham, M. A. Staykova, I. A. Ramshaw, and W. B. Cowden. 1999. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide. J. Immunol. 163: 5278-5286.
55. Zamvil, S. S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8: 579-621.